Akebia Therapeutics (AKBA) Ownership - Who Owns Akebia Therapeutics?

1,641 Followers

Akebia Therapeutics (AKBA) Ownership Overview

2.87% Insiders

8.42% Mutual Funds

2.73% Other Institutional Investors

10.39% ETFs

75.58% Public Companies and

Individual Investors

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 21.55% of the company’s stock is owned by Institutional Investors, 2.87% is owned by Insiders, and 75.58% is owned by Public Companies and Individual Investors.

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 11.16% of the company’s stock is owned by Institutional Investors, 2.87% is owned by Insiders, and 10.39% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2026	John P. Butler	xxxxxxxxxxxxx	$86588

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$345209
Dec 31, 2023	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$280431
Dec 31, 2023	Royce & Associates Llc	xxxxxxxxxxxxx	$39438

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	13,200,404	Institution	4.92%	15,048,461
	10,892,584	Institution	4.06%	12,417,546
	9,826,077	Institution	3.66%	11,201,728
	3,526,992	Insider	1.31%	4,020,771
	2,837,166	Institution	1.06%	3,234,369
	2,644,258	Institution	0.99%	3,014,454
	1,492,485	Institution	0.56%	1,701,433
	1,460,430	Institution	0.54%	1,664,890
	1,288,374	Institution	0.48%	1,468,746
Michael Rockefeller	1,001,360	Institution	0.37%	1,141,550

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
10,892,584	Institution	4.06%	12,417,546
2,837,166	Institution	1.06%	3,234,369
2,644,258	Institution	0.99%	3,014,454
1,460,430	Institution	0.54%	1,664,890
757,990	Institution	0.28%	864,109
729,140	Institution	0.27%	831,220
537,795	Institution	0.20%	613,086
396,648	Institution	0.15%	452,179
348,199	Institution	0.13%	396,947
308,000	Institution	0.11%	351,120

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	7,912,283	Institution	2.95%	8,070,529
iShares Russell 2000 ETF	5,931,817	Institution	2.21%	6,287,726
Vanguard Extended Market ETF	3,007,026	Institution	1.12%	3,067,167
iShares Russell 2000 Value ETF	1,999,508	Institution	0.75%	2,119,478
Vanguard Russell 2000 ETF	1,298,780	Institution	0.48%	1,324,756
Fidelity Enhanced Small Cap ETF	1,288,208	Institution	0.48%	1,417,029
Schwab U.S. Small-Cap ETF	1,262,091	Institution	0.47%	1,388,300
Vanguard Health Care ETF	751,608	Institution	0.28%	766,640
iShares Micro-Cap ETF	647,816	Institution	0.24%	686,685
iShares MSCI USA Small-Cap Multifactor ETF	604,114	Institution	0.23%	640,361

FAQ

Who Owns Akebia Therapeutics (AKBA)?

According to the latest TipRanks data, approximately 2.73% of the company's stock is held by institutional investors, 2.87% is held by insiders, and 75.58% is held by retail investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.73% of Akebia Therapeutics (AKBA) stock is held by institutional investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by retail investors?

According to the latest TipRanks data, approximately 75.58% of Akebia Therapeutics (AKBA) stock is held by retail investors.

Who owns the most shares of Akebia Therapeutics (AKBA)?

Vanguard owns the most shares of Akebia Therapeutics (AKBA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.